Log In
Print
BCIQ
Print
Print this Print this
 

NT-113

  Manage Alerts
Collapse Summary General Information
Company Kanion Pharmaceutical Co. Ltd.
DescriptionOral small molecule inhibitor of EGFR, EGFR2 (HER2; ErbB2; neu) and EGFR4 (HER4; ErbB4)
Molecular Target Epidermal growth factor receptor (EGFR) ; Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionEpidermal growth factor (EGF) receptor inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today